XBiotech Inc. (XBIT) has a negative trailing P/E of -1.6, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -64.11%.
Criteria proven by this page:
Overall SharesGrow Score: 53/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -6.2 | -0.18 | 5.55 | 0.00 | - |
| 2017 | -4.1 | 0.10 | 2.28 | 0.00 | - |
| 2018 | -8.6 | 0.23 | 4.39 | 0.00 | - |
| 2019 | 1.1 | 0.00 | 0.96 | 0.00 | - |
| 2020 | -43.0 | 0.42 | 1.38 | 10.96 | - |
| 2021 | -19.2 | -0.31 | 1.24 | 18.18 | 22.43% |
| 2022 | -3.2 | -0.04 | 0.44 | 26.64 | - |
| 2023 | -4.9 | 0.20 | 0.55 | 0.00 | - |
| 2024 | -3.1 | -0.06 | 0.66 | 0.00 | - |
| 2025 | -1.6 | -0.09 | 0.52 | 0.00 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-1.63 | $0.00 | $-52.76M | - |
| 2017 | $-0.95 | $0.00 | $-33.15M | - |
| 2018 | $-0.59 | $0.00 | $-21.14M | - |
| 2019 | $14.44 | $0.00 | $668.63M | - |
| 2020 | $-0.36 | $44M | $-11.22M | -25.5% |
| 2021 | $-0.58 | $18.39M | $-17.41M | -94.7% |
| 2022 | $-1.08 | $4.01M | $-32.9M | -820.4% |
| 2023 | $-0.81 | $0.00 | $-24.56M | - |
| 2024 | $-1.26 | $0.00 | $-38.53M | - |
| 2025 | $-1.49 | $0.00 | $-45.54M | - |
